✦ LIBER ✦

Safety and immunogenicity of live attenuated human–bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants

✍ Scribed by Mary Lou Clements-Mann; Mamodikoe K Makhene; Jacek Mrukowicz; Peter F Wright; Yasutaka Hoshino; Karen Midthun; Ellen Sperber; Ruth Karron; Albert Z Kapikian

Book ID: 117433269
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 140 KB
Volume: 17
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(98)00497-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of rhesus-huma

Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity

✍ Timo Vesikari; Tiina Varis; Kim Green; Jorge Flores; Albert Z. Kapikian 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 589 KB

Evaluation of safety and immunogenicity

Evaluation of safety and immunogenicity of a live attenuated tetravalent (G1–G4) Bovine-Human Reassortant Rotavirus vaccine (BRV-TV) in healthy Indian adults and infants

✍ Dhingra, M.S.; Kundu, R.; Gupta, M.; Kanungo, S.; Ganguly, N.; Singh, M.P.; Bhat 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 674 KB

A comparative evaluation of the safety a

A comparative evaluation of the safety and immunogenicity of a single dose of unbuffered oral rhesus rotavirus serotype 3, rhesus/human reassortant serotypes 1, 2 and 4 and combined (tetravalent) vaccines in healthy infants

✍ Michael E. Pichichero; Steven M. Marsocci; Anne B. Francis; John L. Green; Frank 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 717 KB